Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcoma

Thirty-six patients with AIDS-associated Kaposi sarcoma (KS) requiring chemotherapy were treated for six 3-week cycles of pegylated liposomal doxorubicin (20 mg/m(2)) plus interleukin-12 (IL-12; 300 ng/kg subcutaneously twice weekly), followed by 500 ng/kg subcutaneous IL-12 twice weekly for up to 3...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Little, Richard F., Aleman, Karen, Kumar, Pallavi, Wyvill, Kathleen M., Pluda, James M., Read-Connole, Elizabeth, Wang, Victoria, Pittaluga, Stefania, Catanzaro, Andrew T., Steinberg, Seth M., Yarchoan, Robert
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2007
Soggetti:
Clinical Trials and Observations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2234790/
https://ncbi.nlm.nih.gov/pubmed/17846226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-06-097568
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi